Futuretech Ii Acquisition CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Ray Lei Chen, CEO and CFO of FutureTech II Acquisition Corp., converted 380,000 shares of Class B Common Stock into 380,000 shares of Class A Common Stock on February 4, 2025.
OTC.Pink
Form 4: FutureTech II Acquisition Corp. Insider Radu Converts Class B Stock to Class A, Increasing Holdings
Zachary C. Radu, a director and indirect owner of FutureTech II Acquisition Corp., converted 2,445,000 shares of Class B Common Stock to Class A Common Stock on February 4, 2025.
OTC.Pink
Director Neil Bush converted 10,000 shares of Class B Common Stock to 10,000 shares of Class A Common Stock in FutureTech II Acquisition Corp.
OTC.Pink
Director Jeffrey Alan Moseley converted 10,000 shares of Class B Common Stock to 10,000 shares of Class A Common Stock in FutureTech II Acquisition Corp.
OTC.Pink
Aroop Zutshi, a former director of FutureTech II Acquisition Corp., converted 10,000 shares of Class B Common Stock into 10,000 shares of Class A Common Stock on February 4, 2025.
OTC.Pink
Michael William Greenall, former CFO and director of FutureTech II Acquisition Corp., converted 20,000 shares of Class B Common Stock into 20,000 shares of Class A Common Stock on February 4, 2025.
OTC.Pink
FutureTech Partners II LLC converted 2,445,000 shares of Class B Common Stock to Class A Common Stock on February 4, 2025.
OTC.Pink
FutureTech II Acquisition Corp. and Longevity Biomedical, Inc. have entered into a definitive agreement for a business combination, aiming to create a Nasdaq-listed biopharmaceutical company focused on longevity.